RanBP9 is a Novel Prognostic and Predictive Biomarker for NSCLC and Affects Cellular Response to Cisplatin and PARP Inhibitors

JOURNAL OF THORACIC ONCOLOGY(2017)

引用 0|浏览3
暂无评分
关键词
PARP inhibitors, RanBP9, Cisplatin
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要